Media Newsroom of

UNION therapeutics A/S

Tuborg Havnevej 18
Copenhagen, Hellerup 2900
UNION therapeutics A/S

UNION is a privately held, clinical stage, pharmaceutical company dedicated to the discovery and development of novel medicine for patients with an unmet need.

UNION therapeutics Launches COVID-19 Program in Collaboration With Institut Pasteur Korea

UNION therapeutics Launches COVID-19 Program in Collaboration With Institut Pasteur Korea

Niclosamide identified as the most potent FDA-approved inhibitor of SARS-CoV-2 by Institut Pasteur Korea Potency of niclosamide >25x higher than chloroquine and >40x higher than remdesivir UNION has extensive knowledge with niclosamide and formulation technology to be deployed in a…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login